FDA Defends Approval Of Generic Acetaminophen OD Drug

Law360, New York (January 18, 2013, 5:18 PM EST) -- The U.S. Food and Drug Administration on Friday urged a Washington federal judge to nix Cumberland Pharmaceuticals Inc.’s bid to block a generic version of its acetaminophen-overdose treatment after it changed the formula over safety concerns, saying Cumberland’s suit would unfairly extend its monopoly on the drug.

Cumberland sued the FDA in November, claiming the agency approved InnoPharma Inc.'s generic version of Acetadote containing edetate disodium, or EDTA, after directing Cumberland to evaluate the feasibility of removing EDTA from the drug due to potential safety concerns...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

CUMBERLAND PHARMACEUTICALS INC. v. FOOD AND DRUG ADMINISTRATION et al


Case Number

1:12-cv-01842

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Judge

Reggie B. Walton

Date Filed

November 12, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.